M Bradley Drummond1. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Obstructive lung disease (OLD), including asthma and chronic obstructive pulmonary disease, has a more substantial prevalence and morbidity in urban populations. This review highlights recent publications examining the epidemiology, risk factors and interventions concerning OLD in urban populations. RECENT FINDINGS: Using a variety of approaches, estimates of asthma prevalence in urban populations range from 5 to 25%. Early life exposures including in-utero cigarette smoke, postnatal bisphenol A, home and school particulates, and environmental air pollution contribute to increased OLD prevalence and symptom manifestations. Individuals with increased exposure to traffic-related pollution demonstrate abnormal inflammatory and lung function profiles. Obesity, more common in urban populations, is likely both a risk factor for asthma as well as contributor to poor control. Interventions targeted at home-based education and assessments are efficacious and cost-effective in improving outcomes of OLD in urban settings. SUMMARY: The burden of OLD in urban populations is driven by maternal, environmental and acquired factors. There are few recent data regarding risk factors and interventions for urban cohorts with chronic obstructive pulmonary disease. The complex interplay of race, socioeconomic status, environmental exposures and healthcare access in the urban population requires continued research efforts.
PURPOSE OF REVIEW: Obstructive lung disease (OLD), including asthma and chronic obstructive pulmonary disease, has a more substantial prevalence and morbidity in urban populations. This review highlights recent publications examining the epidemiology, risk factors and interventions concerning OLD in urban populations. RECENT FINDINGS: Using a variety of approaches, estimates of asthma prevalence in urban populations range from 5 to 25%. Early life exposures including in-utero cigarette smoke, postnatal bisphenol A, home and school particulates, and environmental air pollution contribute to increased OLD prevalence and symptom manifestations. Individuals with increased exposure to traffic-related pollution demonstrate abnormal inflammatory and lung function profiles. Obesity, more common in urban populations, is likely both a risk factor for asthma as well as contributor to poor control. Interventions targeted at home-based education and assessments are efficacious and cost-effective in improving outcomes of OLD in urban settings. SUMMARY: The burden of OLD in urban populations is driven by maternal, environmental and acquired factors. There are few recent data regarding risk factors and interventions for urban cohorts with chronic obstructive pulmonary disease. The complex interplay of race, socioeconomic status, environmental exposures and healthcare access in the urban population requires continued research efforts.
Authors: Alkis Togias; Matthew J Fenton; Peter J Gergen; Daniel Rotrosen; Anthony S Fauci Journal: J Allergy Clin Immunol Date: 2010-03 Impact factor: 10.793
Authors: M Bradley Drummond; Gregory D Kirk; Jacquie Astemborski; Mariah M Marshall; Shruti H Mehta; John F McDyer; Robert H Brown; Robert A Wise; Christian A Merlo Journal: Thorax Date: 2011-11-16 Impact factor: 9.139
Authors: Elizabeth R Woods; Urmi Bhaumik; Susan J Sommer; Sonja I Ziniel; Alaina J Kessler; Elaine Chan; Ronald B Wilkinson; Maria N Sesma; Amy B Burack; Elizabeth M Klements; Lisa M Queenin; Deborah U Dickerson; Shari Nethersole Journal: Pediatrics Date: 2012-02-20 Impact factor: 7.124
Authors: Carlos Flores; Shwu-Fan Ma; María Pino-Yanes; Michael S Wade; Lina Pérez-Méndez; Rick A Kittles; Deli Wang; Srinivas Papaiahgari; Jean G Ford; Rajesh Kumar; Joe G N Garcia Journal: PLoS One Date: 2012-01-03 Impact factor: 3.240
Authors: Jessie C Frazier; Katie M Loveland; Heather J Zimmerman; Steven D Helgerson; Todd S Harwell Journal: Prev Chronic Dis Date: 2011-12-15 Impact factor: 2.830
Authors: Caroline J Lodge; Katrina J Allen; Adrian J Lowe; David J Hill; Cliff S Hosking; Michael J Abramson; Shyamali C Dharmage Journal: Clin Dev Immunol Date: 2011-11-30